Pending — not yet graded
“Bullish on Glenmark Pharmaceuticals, recommending a buy at CMP Rs 2,515 with a target of Rs 2,701 and a stop loss of Rs 2,420. The stock has witnessed a fresh breakout backed by strong volumes, confirming buying interest.”
Nilesh Jain’s track record: 3 graded calls · 95% CI 6–79%
Glenmark PharmaceuticalsBullishCalled 31 Aug 2026
This call hasn't reached its evaluation window yet — the HIT/MISS verdict will appear here once it's graded against real price data. Save it above to find it again from your profile.